Proteomics

Dataset Information

0

Ursolic acid derivative UAOS-Na treats experimental autoimmune encephalomyelitis by immunoregulation and direct anti-demyelination


ABSTRACT: Multiple sclerosis (MS) is a chronic, inflammatory, and demyelinating disease of the central nervous system (CNS). Ursolic acid (UA) can be used in the MS treatment with anti-inflammatory and neuroprotective activities. However, UA is insoluble in water, which may affect its medication effectiveness. In this study, we evaluated the pharmacological effects of UAOS-Na, a water-soluble UA derivative, on experimental autoimmune encephalomyelitis (EAE) mouse, explored its underlying mechanism, and verified the mechanism by in vitro and in vivo experiments. As we expected, UAOS-Na (30 mg/kg/d) delayed the onset time of EAE from 11.78 days post immunization (dpi) to 14.33 dpi, reduced the incidence from 90.0% to 42.9%, and was more effective than UA. UAOS-Na (60 mg/kg/d) significantly decreased the serum levels of IFN-γ, IL-17A, TNF-α and IL-6, reduced the mononuclear cell infiltration of spinal cord, and inhibited the overexpression of key transcription factors T-bet and ROR-γt of EAE mouse spinal cord and spleen. In addition, UAOS-Na attenuated demyelination and astrogliosis in the CNS of EAE and Cuprizone-induced mice. Mechanically, proteomics showed that 217 differential expression proteins (DEPs) were enriched and 215 were upregulated in EAE mice. After UAOS-Na treatment, 52 DEPs were enriched and 49 were downregulated, and these DEPs were markedly enriched in inositol phosphate metabolism, calcium, sphingolipid, cAMP, and antigen processing and presentation (APP) signaling pathways. Among them, there were few studies on APP signaling pathway related with MS. Therefore, we further investigated the effect of UAOS-Na on APP signaling pathway and found that UAOS-Na downregulated the protein levels of Tapbp and H2-T23 in MHC-I antigen presentation pathway and decreased the proliferation of splenic CD8 T cells, thereby inhibiting the CNS infiltration of CD8 T cells. Together, our findings demonstrated that UAOS-Na have both direct anti-demyelination and anti-inflammation effects. And it could reduce the inflammation of MS by downregulating the expression of Tapbp and H2-T23 in the MHC-I antigen presentation pathway.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Spinal Cord

DISEASE(S): Multiple Sclerosis

SUBMITTER: Gao Yuan  

LAB HEAD: Wang Maolin

PROVIDER: PXD045108 | Pride | 2023-11-30

REPOSITORIES: Pride

Similar Datasets

2013-06-30 | E-GEOD-39120 | biostudies-arrayexpress
2013-06-15 | E-GEOD-44333 | biostudies-arrayexpress
2013-06-30 | GSE39120 | GEO
2013-04-03 | GSE39119 | GEO
2023-04-12 | GSE168202 | GEO
2013-04-03 | E-GEOD-39119 | biostudies-arrayexpress
2023-03-31 | GSE223137 | GEO
2019-11-18 | GSE137801 | GEO
2024-01-04 | GSE217529 | GEO
2013-09-09 | E-GEOD-47486 | biostudies-arrayexpress